Published in J Clin Microbiol on July 01, 1984
Enteroaggregative Escherichia coli elaborate a heat-stable enterotoxin demonstrable in an in vitro rabbit intestinal model. J Clin Invest (1991) 2.35
Purification, morphology, and genetics of a new fimbrial putative colonization factor of enterotoxigenic Escherichia coli O159:H4. Infect Immun (1987) 1.86
Identification of enterotoxigenic Escherichia coli with synthetic alkaline phosphatase-conjugated oligonucleotide DNA probes. J Clin Microbiol (1987) 1.76
Comparative study of synthetic oligonucleotide and cloned polynucleotide enterotoxin gene probes to identify enterotoxigenic Escherichia coli. J Clin Microbiol (1987) 1.42
Citrobacter freundii produces an 18-amino-acid heat-stable enterotoxin identical to the 18-amino-acid Escherichia coli heat-stable enterotoxin (ST Ia). Infect Immun (1989) 1.31
Production of Escherichia coli STa-like heat-stable enterotoxin by Citrobacter freundii isolated from humans. J Clin Microbiol (1987) 1.26
Production of neutralizing monoclonal antibodies to Escherichia coli heat-stable enterotoxin. Infect Immun (1985) 1.16
Epidemiological study of a food-borne outbreak of enterotoxigenic Escherichia coli O25:NM by pulsed-field gel electrophoresis and randomly amplified polymorphic DNA analysis. J Clin Microbiol (1998) 1.07
Blinded, two-laboratory comparative analysis of Escherichia coli heat-stable enterotoxin production by using monoclonal antibody enzyme-linked immunosorbent assay, radioimmunoassay, suckling mouse assay, and gene probes. J Clin Microbiol (1986) 1.02
Production of a monoclonal antibody to Vibrio cholerae non-O1 heat-stable enterotoxin (ST) which is cross-reactive with Yersinia enterocolitica ST. Infect Immun (1990) 0.99
Clinical laboratory applications of monoclonal antibodies. Clin Microbiol Rev (1988) 0.91
Heat stable enterotoxin produced by Escherichia coli in acute diarrhoea. Arch Dis Child (1989) 0.88
Association and dissociation of Escherichia coli heat-stable enterotoxin from rat brush border membrane receptors. Infect Immun (1987) 0.87
Evaluation of a competitive enzyme-linked immunosorbent assay for porcine Escherichia coli heat-stable enterotoxin. J Clin Microbiol (1985) 0.87
Evaluation of antisera used for detecting enterotoxigenic Escherichia coli in Sao Paulo. J Clin Microbiol (1985) 0.86
Epitope mapping and characterization of antigenic determinants of heat-stable enterotoxin (STh) of enterotoxigenic Escherichia coli by using monoclonal antibodies. Infect Immun (1993) 0.83
Identification of enterotoxigenic Escherichia coli by colony hybridization with nonradioactive digoxigenin-labeled DNA probes. J Clin Microbiol (1990) 0.81
Detection of heat-stable enterotoxigenic Escherichia coli by hybridization with an RNA transcript probe. J Clin Microbiol (1987) 0.80
Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol (1972) 40.51
Human diarrheal disease caused by enterotoxigenic Escherichia coli. Annu Rev Microbiol (1975) 9.01
Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures. Infect Immun (1979) 7.21
The relationship between two apparently different enterotoxins produced by enteropathogenic strains of Escherichia coli of porcine origin. J Med Microbiol (1970) 6.70
Suckling mouse model for detection of heat-stable Escherichia coli enterotoxin: characteristics of the model. Infect Immun (1976) 5.86
Biological evaluation of a methanol-soluble, heat-stable Escherichia coli enterotoxin in infant mice, pigs, rabbits, and calves. Infect Immun (1978) 4.45
Isolation and nucleotide sequence determination of a gene encoding a heat-stable enterotoxin of Escherichia coli. Infect Immun (1983) 4.14
Amino-acid sequence of a heat-stable enterotoxin produced by human enterotoxigenic Escherichia coli. Eur J Biochem (1982) 2.78
Purification and characterization of heat-stable enterotoxin produced by a strain of E. coli pathogenic for man. J Biol Chem (1980) 2.61
Amino acid sequence of heat-stable enterotoxin produced by Escherichia coli pathogenic for man. J Biol Chem (1981) 2.04
Pathogenesis of enteric diseases caused by Escherichia coli. Adv Vet Sci Comp Med (1974) 2.03
Development of a radioimmunoassay for Escherichia coli heat-stable enterotoxin: comparison with the suckling mouse bioassay. Infect Immun (1981) 1.75
Chemical properties of heat-stable enterotoxins produced by enterotoxigenic Escherichia coli of different host origins. Infect Immun (1983) 1.59
Primary structure determination of Escherichia coli heat-stable enterotoxin of porcine origin. Can J Biochem Cell Biol (1983) 1.43
Structure of a heat-stable enterotoxin produced by a human strain of Escherichia coli. Differences from the toxin of another human strain suggest the presence of compensated amino acid exchanges. FEBS Lett (1983) 1.23
Purification and characterization of heat-stable enterotoxin from bovine enterotoxigenic Escherichia coli. Infect Immun (1983) 1.00
Production and evaluation of antibody to the heat-stable enterotoxin from a human strain of enterotoxigenic Escherichia coli. Appl Environ Microbiol (1981) 0.95
Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines. Infect Immun (1983) 12.81
Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. J Infect Dis (1982) 8.05
Suckling mouse model for detection of heat-stable Escherichia coli enterotoxin: characteristics of the model. Infect Immun (1976) 5.86
Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro. Gut (1972) 4.59
Invasion of HeLa cells by Salmonella typhimurium: a model for study of invasiveness of Salmonella. J Infect Dis (1973) 4.22
Inhibition of in vitro protein synthesis by Shigella dysenteriae 1 toxin. Biochem Biophys Res Commun (1976) 3.30
Biological properties of Shigella flexneri 2A toxin and its serological relationship to Shigella dysenteriae 1 toxin. Infect Immun (1977) 2.94
Influence of gastric acidity on bacterial and parasitic enteric infections. A perspective. Ann Intern Med (1973) 2.91
The Department of Health's "two week standard" for bowel cancer: is it working? Gut (2004) 2.88
Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography. Infect Immun (1980) 2.82
Pathogenesis of salmonellosis. Studies of fluid secretion, mucosal invasion, and morphologic reaction in the rabbit ileum. J Clin Invest (1973) 2.78
Purification and characterization of heat-stable enterotoxin produced by a strain of E. coli pathogenic for man. J Biol Chem (1980) 2.61
Training in large bowel cancer surgery: observations from three prospective regional United Kingdom audits. BMJ (1999) 2.44
The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J Biol Chem (1992) 2.40
Indomethacin and perforated duodenal ulcer. Br Med J (1980) 2.21
Mice lacking the basolateral Na-K-2Cl cotransporter have impaired epithelial chloride secretion and are profoundly deaf. J Biol Chem (1999) 2.15
Amino acid sequence of heat-stable enterotoxin produced by Escherichia coli pathogenic for man. J Biol Chem (1981) 2.04
Production of exoenzyme S during Pseudomonas aeruginosa infections of burned mice. Infect Immun (1979) 1.86
Bascom's operation in the day-surgical management of symptomatic pilonidal sinus. Br J Surg (2000) 1.85
Pathophysiology of Shigella diarrhea in the rhesus monkey: intestinal transport, morphological, and bacteriological studies. Gastroenterology (1975) 1.83
Salmonella enteritis. I. Role of reduced gastric secretion in pathogenesis. Am J Dig Dis (1971) 1.82
Development of a radioimmunoassay for Escherichia coli heat-stable enterotoxin: comparison with the suckling mouse bioassay. Infect Immun (1981) 1.75
Salmonella enteritis. II. Fulminant diarrhea in and effects on the small intestine. Am J Dig Dis (1971) 1.74
Changes over time in socioeconomic inequalities in breast and rectal cancer survival in England and Wales during a 32-year period (1973-2004): the potential role of health care. Ann Oncol (2011) 1.72
Pathogenesis of Salmonella-mediated intestinal fluid secretion. Activation of adenylate cyclase and inhibition by indomethacin. Gastroenterology (1975) 1.71
Retention of water-borne bacteria by membrane filters. Part I: Bacterial challenge tests on 0.2 and 0.22 micron rated filters. PDA J Pharm Sci Technol (2001) 1.69
Effect of purified Escherichia coli heat-stable enterotoxin on intestinal cyclic nucleotide metabolism and fluid secretion. Infect Immun (1979) 1.60
Pathophysiology of Salmonella diarrhea in the Rhesus monkey: Intestinal transport, morphological and bacteriological studies. Gastroenterology (1974) 1.56
Hydrodynamic structure of bovine serum albumin determined by transient electric birefringence. Biophys J (1975) 1.52
Cleft closure for the treatment of pilonidal sinus disease. Colorectal Dis (2011) 1.52
Mechanism of action of Escherichia coli heat stable enterotoxin in a human colonic cell line. J Clin Invest (1988) 1.47
Indomethacin inhibition of Salmonella typhimurium, Shigella flexneri, and cholera-mediated rabbit ileal secretion. J Infect Dis (1974) 1.44
Lack of clinically significant contact system activation during platelet concentrate filtration by leukocyte removal filters. Blood (1998) 1.42
Theory and application of static field inhomogeneity effects in gradient-echo imaging. J Magn Reson Imaging (1997) 1.40
Importance of the intestinal inflammatory reaction in salmonella-mediated intestinal secretion. Infect Immun (1979) 1.38
Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo. Infect Immun (1988) 1.36
Small intestinal mucosal injury in the experimental blind loop syndrome. Light- and electron-microscopic and histochemical studies. Gastroenterology (1975) 1.34
More on kininogen measurements in platelet concentrates that are white cell (WBC) reduced with WBC-reduction filters. Transfusion (1996) 1.33
Pathogenesis of acute bacterial diarrheal disorders. Annu Rev Med (1981) 1.32
Revised amino acid sequence for a heat-stable enterotoxin produced by an Escherichia coli strain (18D) that is pathogenic for humans. Infect Immun (1985) 1.32
Evidence of the effect of 'specialization' on the management, surgical outcome and survival from colorectal cancer in Wessex. Br J Surg (2003) 1.32
Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody. Infect Immun (1990) 1.31
Rapid screening assay for toxic shock syndrome toxin production by Staphylococcus aureus. J Clin Microbiol (1984) 1.31
Citrobacter freundii produces an 18-amino-acid heat-stable enterotoxin identical to the 18-amino-acid Escherichia coli heat-stable enterotoxin (ST Ia). Infect Immun (1989) 1.31
In vitro production of an extracellular protease by Legionella pneumophila. Infect Immun (1981) 1.26
Jejunal brush border injury and impaired sugar and amino acid uptake in the blind loop syndrome. Gastroenterology (1974) 1.25
Validation of a volunteer model of cholera with frozen bacteria as the challenge. Infect Immun (1998) 1.23
Binding of Escherichia coli heat-stable enterotoxin to receptors on rat intestinal cells. Am J Physiol (1983) 1.19
Mechanisms of Shigella pathogenesis. Am J Clin Nutr (1972) 1.17
Evaluation of Delorme's procedure as a treatment for full-thickness rectal prolapse. Br J Surg (2000) 1.16
Fluid and electrolyte transport in rhesus monkeys challenged intracecally with Shigella flexneri 2a. Infect Immun (1976) 1.16
Production of neutralizing monoclonal antibodies to Escherichia coli heat-stable enterotoxin. Infect Immun (1985) 1.16
Activation of intestinal mucosal adenylate cyclase by Shigella dysenteriae I enterotoxin. Gastroenterology (1976) 1.13
IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death. Cell Death Differ (2009) 1.13
Biological and immunological characteristics of 125I-4Tyr and -18Tyr Escherichia coli heat-stable enterotoxin species purified by high-performance liquid chromatography. Anal Biochem (1985) 1.12
Age-related differences in receptors for Escherichia coli heat-stable enterotoxin in the small and large intestine of children. Gastroenterology (1988) 1.11
Retention of water-borne bacteria by membrane filters. Part II: Scanning electron microscopy (SEM) and fatty acid methyl ester (FAME) characterization of bacterial species recovered downstream of 0.2/0.22 micron rated filters. PDA J Pharm Sci Technol (2001) 1.10
Competition between bacteria and intrinsic factor for vitamin B 12 : implications for vitamin B 12 malabsorption in intestinal bacterial overgrowth. Gastroenterology (1972) 1.10
Effect of indomethacin on intestinal water transport in salmonella-infected rhesus monkeys. Infect Immun (1977) 1.07
Mice lacking the guanylyl cyclase C receptor are resistant to STa-induced intestinal secretion. Biochem Biophys Res Commun (1997) 1.07
Vitamin B12 uptake by intestinal microorganisms: mechanism and relevance to syndromes of intestinal bacterial overgrowth. J Clin Invest (1971) 1.07
Binding of E. coli heat-stable enterotoxin to rat intestinal brush borders and to basolateral membranes. Dig Dis Sci (1987) 1.07
Retention of water-borne bacteria by membrane filters. Part III: Bacterial challenge tests on 0.1 micron rated filters. PDA J Pharm Sci Technol (2001) 1.06
Disease stage and psychosocial outcomes in colorectal cancer. Colorectal Dis (2008) 1.05
Social deprivation and outcomes in colorectal cancer. Br J Surg (2006) 1.05
Shigellosis and Escherichia coli diarrhea: relative importance of invasive and toxigenic mechanisms. Am J Clin Nutr (1979) 1.05
Acute diarrhea: a practical review. Am J Med (1999) 1.04
Method for qualifying microbial removal performance of 0.1 micron rated filters. Part II: preliminary characterization of Hydrogenophaga (formerly Pseudomonas) pseudoflava for use as a standard challenge organism to qualify 0.1 micron rated filters. PDA J Pharm Sci Technol (2001) 1.04
Comparison of circumferential margin involvement between restorative and nonrestorative resections for rectal cancer. Colorectal Dis (2005) 1.03
Method for qualifying microbial removal performance of 0.1 micron rated filters. Part I: characterization of water isolates for potential use as standard challenge organisms to qualify 0.1 micron rated filters. PDA J Pharm Sci Technol (2001) 1.02
Blinded, two-laboratory comparative analysis of Escherichia coli heat-stable enterotoxin production by using monoclonal antibody enzyme-linked immunosorbent assay, radioimmunoassay, suckling mouse assay, and gene probes. J Clin Microbiol (1986) 1.02
Usefulness of colonoscopy with biopsy in the evaluation of patients with chronic diarrhea. Am J Gastroenterol (2001) 1.02
Synthesis and proof of structure of the new amino acid in prothrombin. Biochem Biophys Res Commun (1975) 1.01
Method for qualifying microbial removal performance of 0.1 micron rated filters. Part III: bacterial challenge tests on 0.2/0.22 and 0.1 micron rated filter cartridges with Hydrogenophaga (formerly Pseudomonas) pseudoflava. PDA J Pharm Sci Technol (2001) 1.00
Na+-K+)-stimulated adenosinetriphosphatase in isolated intestinal villus tip and crypt cells. Biochim Biophys Acta (1974) 0.98
Gastric mucosal lesions produced by intravenous infusion of aspirin in cats. Gastroenterology (1976) 0.98
Small and large intestinal guanylate cyclase activity in children: effect of age and stimulation by Escherichia coli heat-stable enterotoxin. Pediatr Res (1987) 0.98
Comparison of receptors for Escherichia coli heat-stable enterotoxin: novel receptor present in IEC-6 cells. Am J Physiol (1993) 0.97
A hospital food-borne outbreak of diarrhea caused by Bacillus cereus: clinical, epidemiologic, and microbiologic studies. J Infect Dis (1979) 0.97
Hepatic inactivation of gastrins of various chain lengths in dogs. Gastroenterology (1978) 0.96
The guanylin/STa receptor is expressed in crypts and apical epithelium throughout the mouse intestine. Biochem Biophys Res Commun (1996) 0.96
Protection of rabbits in an infection model of toxic shock syndrome (TSS) by a TSS toxin-1-specific monoclonal antibody. Infect Immun (1988) 0.96
Characterization of human beta-interferon-binding sites on human cells. J Biol Chem (1985) 0.94
Comparison of the biological actions of three purified heat-stable enterotoxins: effects on ion transport and guanylate cyclase activity in rabbit ileum in vitro. Infect Immun (1981) 0.94
THE NEW ERGOT ALKALOID. Science (1936) 0.94
ApoE polymorphisms and diarrheal outcomes in Brazilian shanty town children. Braz J Med Biol Res (2010) 0.93
Effect of E. coli heat-stable enterotoxin on colonic transport in guanylyl cyclase C receptor-deficient mice. Am J Physiol Gastrointest Liver Physiol (2001) 0.93
Implantation metastasis from adenocarcinoma of sigmoid colon into fistula in ano. J R Soc Med (1992) 0.92
A gradient in expression of the Escherichia coli heat-stable enterotoxin receptor exists along the villus-to-crypt axis of rat small intestine. Biochem Biophys Res Commun (1992) 0.92
Chemiluminescent detection of DNA on nylon membranes. Biotechniques (1992) 0.92
Escherichia coli enterotoxin (STa) binds to receptors, stimulates guanyl cyclase, and impairs absorption in rat colon. Gastroenterology (1992) 0.92
The immature rat small intestine exhibits an increased sensitivity and response to Escherichia coli heat-stable enterotoxin. Pediatr Res (1986) 0.92
Antifreeze glycoproteins from the blood of an antarctic fish. The structure of the proline-containing glycopeptides. J Biol Chem (1978) 0.91
Physiological changes after Delorme's procedure for full-thickness rectal prolapse. Br J Surg (1995) 0.91